Embracing Operational Excellence

At Genetics, every day, we ensure seamless operations to deliver effective and quality medications to patients in need. Our drug manufacturing process is systematic, complex and science-based. With strong team performance, and an exceptional market surveillance, Genetics became pioneers in manufacturing CNS products, which radically improved mental health and wellbeing of people in Pakistan- a crisis previously unaddressed by pharmaceuticals in the region.

Currently, with a greater focus on manufacturing automation, high speed blistering packaging machines, and automatic cartooning machines have been installed which has significantly increased our production capacity by five folds. In addition, before our product is launched in the market, it has to clear a safety review, and undergo a thorough validation of its manufacturing process.

In today's dynamic and competitive business landscape, ensuring the highest quality and reliability of our products and services is paramount. As part of our commitment to excellence, Genetics is proud to announce its future plans to obtain ISO/IEC 17025 lab accreditation. This accreditation will not only validate our capabilities but also enhance our reputation, customer trust, and operational efficiency.

At Genetics, we have:

  • A GMP sanctioned manufacturing facility ensuring unlimited supply of over 200 products in accordance with applicable laws and regulations.
  • Manufacturing capabilities that comprise of oral solutions, general tablets, capsules, as well as modified release oral solids.
  • A state-of-the-art production plant equipped with imported machinery from Italy and China.
  • Advanced production facilities that are continuously upgraded and improved to keep pace with novel innovations and technological advancements.